α2-Adrenergic blockade mimics the enhancing effect of chronic stress on breast cancer progression

Psychoneuroendocrinology

Volumn 51, Issue , 2015, Pages 262-270

  Lamkin, Donald M ^a   Sung, Ha Yeon ^a   Yang, Gyu Sik ^a   David, John M ^b   Ma, Jeffrey C Y ^a,b   Cole, Steve W ^a,b,c   Sloan, Erica K ^a,b,d,e  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d MONASH UNIVERSITY   (Australia)

^e PETER MACCALLUM CANCER CENTRE   (Australia)

Author keywords

Bioluminescent imaging; Breast cancer; Catecholamines; Metastasis; Restraint stress; Sympathetic nervous system; Adrenergic receptor

Indexed keywords

ALPHA 2 ADRENERGIC RECEPTOR; BETA ADRENERGIC RECEPTOR; CATECHOLAMINE; EFAROXAN; PHENTOLAMINE; PRAZOSIN; PROPRANOLOL; ALPHA 1 ADRENERGIC RECEPTOR BLOCKING AGENT; ALPHA 2 ADRENERGIC RECEPTOR BLOCKING AGENT; BENZOFURAN DERIVATIVE; IMIDAZOLE DERIVATIVE;

ADRENERGIC RECEPTOR BLOCKING; ADRENERGIC TRANSMISSION; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BREAST CANCER; CANCER CELL LINE; CANCER GROWTH; CELL PROLIFERATION; CHRONIC STRESS; CONTROLLED STUDY; DISTANT METASTASIS; FEMALE; GENE EXPRESSION; HUMAN; HUMAN CELL; IN VITRO STUDY; MDA MB 231HM CELL LINE; MOUSE; NONHUMAN; SIGNAL TRANSDUCTION; TUMOR VOLUME; ANIMAL; DISEASE COURSE; DRUG EFFECTS; EXERCISE; EXPERIMENTAL MAMMARY NEOPLASM; MENTAL STRESS; METASTASIS; PATHOLOGY; PHYSIOLOGICAL STRESS;

ADRENERGIC ALPHA-1 RECEPTOR ANTAGONISTS; ADRENERGIC ALPHA-2 RECEPTOR ANTAGONISTS; ANIMALS; BENZOFURANS; CELL PROLIFERATION; DISEASE PROGRESSION; FEMALE; IMIDAZOLES; MAMMARY NEOPLASMS, EXPERIMENTAL; MICE; NEOPLASM METASTASIS; PRAZOSIN; RESTRAINT, PHYSICAL; SIGNAL TRANSDUCTION; STRESS, PHYSIOLOGICAL; STRESS, PSYCHOLOGICAL;

EID: 84920614543     PISSN: 03064530     EISSN: 18733360     Source Type: Journal    
DOI: 10.1016/j.psyneuen.2014.10.004     Document Type: Article

References (30)

1. Antoni M.H., Lutgendorf S.K., Cole S.W., Dhabhar F.S., Sephton S.E., McDonald P.G., Stefanek M., Sood A.K. The influence of bio-behavioural factors on tumour biology: pathways and mechanisms. Nat. Rev. Cancer 2006, 6:240-248.
2. Barron T.I., Connolly R.M., Sharp L., Bennett K., Visvanathan K. Beta blockers and breast cancer mortality: a population-based study. J. Clin. Oncol. 2011, 29:2635-2644.
3. Botteri E., Munzone E., Rotmensz N., Cipolla C., De Giorgi V., Santillo B., Zanelotti A., Adamoli L., Colleoni M., Viale G., Goldhirsch A., Gandini S. Therapeutic effect of β-blockers in triple-negative breast cancer postmenopausal women. Breast Cancer Res. Treat. 2013, 140:567-575.
4. Boyd K., Hilas O. α-Adrenergic blockers for the treatment of lower-urinary-tract symptoms and dysfunction in women. Ann. Pharmacother. 2014, 48:711-722.
5. Bruzzone A., Piñero C.P., Castillo L.F., Sarappa M.G., Rojas P., Lanari C., Lüthy I.A. Alpha2-adrenoceptor action on cell proliferation and mammary tumour growth in mice. Br. J. Pharmacol. 2008, 155:494-504.
6. Bruzzone A., Vanzulli S.I., Soldati R., Giulianelli S., Lanari C., Lüthy I.A. Novel human breast cancer cell lines IBH-4, IBH-6, and IBH-7 growing in nude mice. J. Cell. Physiol. 2009, 219:477-484.
7. Chang X.Z., Li D.Q., Hou Y.F., Wu J., Lu J.S., Di G.H., Jin W., Ou Z.L., Shen Z.Z., Shao Z.M. Identification of the functional role of AF1Q in the progression of breast cancer. Breast Cancer Res. Treat. 2008, 111:65-78.
8. Chida Y., Hamer M., Wardle J., Steptoe A. Do stress-related psychosocial factors contribute to cancer incidence and survival?. Nat. Clin. Pract. Oncol. 2008, 5:466-475.
9. Dinsmore W.W., Wyllie M.G. Vasoactive intestinal polypeptide/phentolamine for intracavernosal injection in erectile dysfunction. BJU Int. 2008, 102:933-937.
10. Hein L., Altman J.D., Kobilka B.K. Two functionally distinct a2-adrenergic receptors regulate sympathetic neurotransmission. Nature 1999, 402:181-184.
11. Hermann G., Beck F.M., Tovar C.A., Malarkey W.B., Allen C., Sheridan J.F. Stress-induced changes attributable to the sympathetic nervous system during experimental influenza viral infection in DBA/2 inbred mouse strain. J Neuroimmunol. 1994, 53:173-180.
12. Kaminskas L.M., Ascher D.B., McLeod V.M., Herold M.J., Le C.P., Sloan E.K., Porter C.J. PEGylation of interferon α2 improves lymphatic exposure after subcutaneous and intravenous administration and improves antitumour efficacy against lymphatic breast cancer metastases. J. Control. Rel 2013, 168:200-208.
13. Koolhaas J.M., Bartolomucci A., Buwalda B., de Boer S.F., Flügge G., Korte S.M., Meerlo P., Murison R., Olivier B., Palanza P., Richter-Levin G., Sgoifo A., Steimer T., Stiedl O., van Dijk G., Wöhr M., Fuchs E. Stress revisited: a critical evaluation of the stress concept. Neurosci. Biobehav. Rev. 2011, 35:1291-1301.
14. Kvetnansky R., Sabban E.L., Palkovits M. Catecholaminergic systems in stress: structural and molecular genetic approaches. Physiol. Rev. 2009, 89:535-606.
15. Madden K.S., Szpunar M.J., Brown E.B. β-Adrenergic receptors (β-AR) regulate VEGF and IL-6 production by divergent pathways in high β-AR-expressing breast cancer cell lines. Breast Cancer Res. Treat. 2011, 130:747-758.
16. Manni L., Di Fausto V., Fiore M., Aloe L. Repeated restraint and nerve growth factor administration in male and female mice: effect on sympathetic and cardiovascular mediators of the stress response. Curr. Neurovasc. Res. 2008, 5:1-12.
17. McCulloch C.E., Searle S.R., Neuhaus J.M. Generalized, Linear, and Mixed Models 2008, John Wiley & Sons, Hoboken, NJ. 2nd ed.
18. Melhem-Bertrandt A., Chavez-Macgregor M., Lei X., Brown E.N., Lee R.T., Meric-Bernstam F., Sood A.K., Conzen S.D., Hortobagyi G.N., Gonzalez-Angulo A.M. Beta-blocker use is associated with improved relapse-free survival in patients with triple-negative breast cancer. J. Clin. Oncol. 2011, 29:2645-2652.
19. Pérez Piñero C., Bruzzone A., Sarappa M.G., Castillo L.F., Lüthy I.A. Involvement of α2- and β2-adrenoceptors on breast cancer cell proliferation and tumour growth regulation. Br. J. Pharmacol. 2012, 166:721-736.
20. Powe D.G., Voss M.J., Zänker K.S., Habashy H.O., Green A.R., Ellis I.O., Entschladen F. Beta-blocker drug therapy reduces secondary cancer formation in breast cancer and improves cancer specific survival. Oncotarget 2010, 1:628-638.
21. Raskind M.A., Peterson K., Williams T., Hoff D.J., Hart K., Holmes H., Homas D., Hill J., Daniels C., Calohan J., Millard S.P., Rohde K., O'Connell J., Pritzl D., Feiszli K., Petrie E.C., Gross C., Mayer C.L., Freed M.C., Engel C., Peskind E.R. A trial of prazosin for combat trauma PTSD with nightmares in active-duty soldiers returned from Iraq and Afghanistan. Am. J. Psychiatry 2013, 170:1003-1010.
22. Scheibner J., Trendelenburg A.U., Hein L., Starke K. Frequency-noradrenaline release relationships examined in a2A-, a2B- and a2C-adrenoceptor-deficient mice. Naunyn Schmiedebergs Arch. Pharmacol. 2001, 364:321-328.
23. Schelb V., Göbel I., Khairallah L., Zhou H., Cox S.L., Trendelenburg A.U., Hein L., Starke K. Postnatal development of presynaptic receptors that modulate noradrenaline release in mice. Naunyn Schmiedebergs Arch. Pharmacol. 2001, 364:359-371.
24. Sloan E.K., Priceman S.J., Cox B.F., Yu S., Pimentel M.A., Tangkanangnukul V., Arevalo J.M., Morizono K., Karanikolas B.D., Wu L., Sood A.K., Cole S.W. The sympathetic nervous system induces a metastatic switch in primary breast cancer. Cancer Res. 2010, 70:7042-7052.
25. Spatz E.S., Canavan M.E., Desai M.M., Krumholz H.M., Lindau S.T. Sexual activity and function among middle-aged and older men and women with hypertension. J. Hypertens. 2013, 31:1096-1105.
26. Starke K. Presynaptic autoreceptors in the third decade: focus on alpha2-adrenoceptors. J. Neurochem. 2001, 78:685-693.
27. Szpunar M.J., Burke K.A., Dawes R.P., Brown E.B., Madden K.S. The antidepressant desipramine and α2-adrenergic receptor activation promote breast tumor progression in association with altered collagen structure. Cancer Prev. Res. (Phila) 2013, 6:1262-1272.
28. Thaker P.H., Han L.Y., Kamat A.A., Arevalo J.M., Takahashi R., Lu C., Jennings N.B., Armaiz-Pena G., Bankson J.A., Ravoori M., Merritt W.M., Lin Y.G., Mangala L.S., Kim T.J., Coleman R.L., Landen C.N., Li Y., Felix E., Sanguino A.M., Newman R.A., Lloyd M., Gershenson D.M., Kundra V., Lopez-Berestein G., Lutgendorf S.K., Cole S.W., Sood A.K. Chronic stress promotes tumor growth and angiogenesis in a mouse model of ovarian carcinoma. Nat. Med. 2006, 12:939-944.
29. Trendelenburg A.U., Klebroff W., Hein L., Starke K. A study of presynaptic alpha2-autoreceptors in alpha2A/D-, alpha2B- and alpha2C-adrenoceptor-deficient mice. Naunyn Schmiedebergs Arch. Pharmacol. 2001, 364:117-130.
30. Vázquez S.M., Pignataro O., Luthy I.A. Alpha2-adrenergic effect on human breast cancer MCF-7 cells. Breast Cancer Res. Treat. 1999, 55:41-49.